STAVE - SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS
DEAD
Serial Number
77813061
Owner
BRISTOL-MYERS SQUIBB COMPANYAttorney
Tanya Fickenscher LeonardFiling Date
Aug 26, 2009
STAVE - SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS Trademark
Serial Number: 77813061
STAVE - SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS is a trademark filed by
BRISTOL-MYERS SQUIBB COMPANY
on August 26, 2009. The trademark is classified under Class 42 (Computer & Scientific).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
August 26, 2009
Registration Date
Not Registered
Goods & Services
Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
Filing History
ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Apr 12, 2010 MAB1
ABANDONMENT - EXPRESS MAILED
Apr 12, 2010 ABN1
TEAS EXPRESS ABANDONMENT RECEIVED
Apr 9, 2010 EXAR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 28, 2009 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 28, 2009 REAP
NON-FINAL ACTION MAILED
Nov 6, 2009 CNRT
NON-FINAL ACTION WRITTEN
Nov 5, 2009 CNRT
ASSIGNED TO EXAMINER
Nov 5, 2009 DOCK
NOTICE OF PSEUDO MARK MAILED
Sep 4, 2009 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 3, 2009 NWOS
NEW APPLICATION ENTERED
Sep 1, 2009 NWAP
